96 related articles for article (PubMed ID: 11408801)
1. Interferon alpha induction of Stat1 and Stat2 and their prognostic significance in carcinoid tumors.
Zhou Y; Wang S; Gobl A; Oberg K
Oncology; 2001; 60(4):330-8. PubMed ID: 11408801
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
3. Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours.
Zhou Y; Gobl A; Wang S; Jacobsen MB; Janson ET; Haines GK; Radosevich JA; Oberg K
Eur J Cancer; 1998 Dec; 34(13):2046-52. PubMed ID: 10070309
[TBL] [Abstract][Full Text] [Related]
4. Interferon-mediated activation of the STAT signaling pathway in a human carcinoid tumor.
Wang S; Tyring SK; Townsend CM; Evers BM
Ann Surg Oncol; 1998; 5(7):642-9. PubMed ID: 9831114
[TBL] [Abstract][Full Text] [Related]
5. Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs.
Melen K; Kinnunen L; Julkunen I
J Biol Chem; 2001 May; 276(19):16447-55. PubMed ID: 11150296
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons.
Matikainen S; Ronni T; Lehtonen A; Sareneva T; Melén K; Nordling S; Levy DE; Julkunen I
Cell Growth Differ; 1997 Jun; 8(6):687-98. PubMed ID: 9186002
[TBL] [Abstract][Full Text] [Related]
7. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
[TBL] [Abstract][Full Text] [Related]
8. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha.
Hung WC; Chuang LY
Br J Cancer; 1999 May; 80(5-6):705-10. PubMed ID: 10360647
[TBL] [Abstract][Full Text] [Related]
9. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages.
Lehtonen A; Matikainen S; Julkunen I
J Immunol; 1997 Jul; 159(2):794-803. PubMed ID: 9218597
[TBL] [Abstract][Full Text] [Related]
10. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling.
Gotoh B; Takeuchi K; Komatsu T; Yokoo J
J Virol; 2003 Mar; 77(6):3360-70. PubMed ID: 12610111
[TBL] [Abstract][Full Text] [Related]
11. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha-induced activation of signal transducer and activator of transcription proteins in malignant melanoma.
Carson WE
Clin Cancer Res; 1998 Sep; 4(9):2219-28. PubMed ID: 9748142
[TBL] [Abstract][Full Text] [Related]
13. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation.
Stancato LF; David M; Carter-Su C; Larner AC; Pratt WB
J Biol Chem; 1996 Feb; 271(8):4134-7. PubMed ID: 8626752
[TBL] [Abstract][Full Text] [Related]
14. Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy.
Lesinski GB; Valentino D; Hade EM; Jones S; Magro C; Chaudhury AR; Walker MJ; Carson WE
Cancer Immunol Immunother; 2005 Sep; 54(9):815-25. PubMed ID: 15668815
[TBL] [Abstract][Full Text] [Related]
15. Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells.
Clifford JL; Yang X; Walch E; Wang M; Lippman SM
Mol Cancer Ther; 2003 May; 2(5):453-9. PubMed ID: 12748307
[TBL] [Abstract][Full Text] [Related]
16. Constitutive STAT1 tyrosine phosphorylation in U937 monocytes overexpressing the TYK2 protein tyrosine kinase does not induce gene transcription.
Eilers A; Kanda K; Klose B; Krolewski J; Decker T
Cell Growth Differ; 1996 Jun; 7(6):833-40. PubMed ID: 8780896
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2.
Brzózka K; Finke S; Conzelmann KK
J Virol; 2006 Mar; 80(6):2675-83. PubMed ID: 16501077
[TBL] [Abstract][Full Text] [Related]
18. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
[TBL] [Abstract][Full Text] [Related]
20. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals.
Gupta S; Yan H; Wong LH; Ralph S; Krolewski J; Schindler C
EMBO J; 1996 Mar; 15(5):1075-84. PubMed ID: 8605877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
